Cardinal Health, Inc.
CAH
Market Cap$25.78B
Close$
Earnings Call Q3 2023
May 4, 2023 - AI Summary
Cardinal Health reported strong results for the third quarter of fiscal year 2023, with total revenue increasing by 13% to $50.5 billion and gross margin increasing by 6% to $1.8 billion.
The Pharma segment led the growth, with revenue increasing by 14% to $47 billion and segment profit increasing by 23% to $600 million. This was driven by strong demand for pharmaceutical products, particularly from large customers, as well as a higher contribution from brand and specialty products.
The Medical segment saw a decline in revenue of 5% to $3.7 billion and a significant decrease in segment profit of 66% to $20 million. This was primarily due to lower product volumes and unfavorable sales mix, although there were some positive non-recurring adjustments in the quarter.
Exclusive for Stockcircle Pro members
Sign up
$262.51
152.9% upside
Current Fair Value
152.9% upsideUndervalued by 152.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.78 Billion |
|---|---|
| Enterprise Value | $25.91 Billion |
| Dividend Yield | $1.9879 (1.88%) |
| Earnings per Share | $2.53 |
| Beta | 0.29 |
| Outstanding Shares | 243,233,153 |
| Avg 30 Day Volume | 1,550,237 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 40.35 |
|---|---|
| PEG | -10.86 |
| Price to Sales | 0.12 |
| Price to Book Ratio | -6.92 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | 11.27 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | -1.37 |
Revenue Sources
No data
ESG Score
No data